Skip to content

Evolus

US · EOLS #3736 by market cap Listed 2018
6.52 -0.48 -6.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13
    Market Newswire · 2026/11/5
  • Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)
    TipRanks · 2026/9/17
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS)
    TipRanks · 2026/5/5
  • Rating change
    Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $19
    Market Newswire · 2026/1/10
  • Rating change
    Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $15
    Market Newswire · 2026/2/4
  • A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $20
    Market Newswire · 2026/11/6
  • BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13
    Market Newswire · 2026/10/15
  • Company notice
    Energy One Ltd: ENGIE in Australia selects EOLs EnergyOffer
    N/A · 2016/12/22
  • Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $15
    Market Newswire · 2026/9/11
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Evolus (EOLS), Upstream Bio, Inc. (UPB)
    TipRanks · 2026/2/4
  • Rating change
    A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $15
    Market Newswire · 2026/3/4
  • Rating change
    BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $18
    Market Newswire · 2025/12/31
  • Rating change
    Leerink Partners Maintains Evolus(EOLS.US) With Buy Rating
    Market Newswire · 2026/9/17
  • Rating change
    Needham Maintains Evolus(EOLS.US) With Hold Rating
    Market Newswire · 2026/8/7
  • Company notice
    Energy One Ltd: Leadership For EOL's Next Era
    ASX · 2025/7/17
  • Rating change
    Stifel Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $17
    Market Newswire · 2026/1/13
  • Rating change
    Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/8/6
  • Rating change
    BTIG Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $13
    Market Newswire · 2026/1/22
  • Rating change
    A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $17
    Market Newswire · 2026/8/6
  • Rating change
    H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $20
    Market Newswire · 2026/1/10
  • Rating change
    Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $19
    Market Newswire · 2025/12/2
  • H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13
    Market Newswire · 2026/8/25
  • Rating change
    A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $18 to $20
    Market Newswire · 2025/11/7
  • Rating change
    Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Raises Target Price to $20
    Market Newswire · 2025/11/6
  • BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13
    Market Newswire · 2026/8/7

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Evolus discussion 0 comments

Add a comment